On October 19, 2017 Cerus Corporation (NASDAQ:CERS) reported that its third quarter results will be released on Thursday, November 2, 2017, after the close of the stock market (Press release, Cerus, OCT 19, 2017, View Source [SID1234521025]). The company will host a conference call and webcast at 4:15 PM ET that afternoon, during which management will discuss the company’s financial results and provide a general business overview and outlook.

To access the live webcast, please visit the Investor Relations page of the company’s website at View Source Alternatively, you may access the live conference call by dialing 866-235-9006 (U.S.) or 631-291-4549 (international).

A replay will be available on the company’s website, or by dialing (855) 859-2056 (U.S.) or (404) 537-3406 (international) and entering conference ID number 82994688. The replay will be available approximately three hours after the call through November 16, 2017.

On October 19, 2017 PTC Therapeutics, Inc. (NASDAQ: PTCT) reported that the Company will host a webcast conference call to report its third quarter financial results and provide an update on the company’s business and outlook on Thursday, November 2, 2017 at 4:30 p.m. (ET) after the closing of the market (Press release, PTC Therapeutics, OCT 19, 2017, View Source [SID1234521029]).

The call can be accessed by dialing (877) 303-9216 (domestic) or (973) 935-8152 (international) five minutes prior to the start of the call and providing the passcode 2261347. A live, listen-only webcast of the conference call can be accessed on the investor relations section of the PTC website at www.ptcbio.com. A webcast replay of the call will be available approximately two hours after completion of the call and will be archived on the company’s website for two weeks.

On October 19, 2017 Alkermes plc (NASDAQ: ALKS) reported that it will host a conference call and webcast presentation at 8:30 a.m. ET (1:30 p.m. BST) on Thursday, Oct. 26, 2017, to discuss the company’s third quarter 2017 financial results. Management will also provide an update on the company (Press release, Alkermes, OCT 19, 2017, View Source [SID1234521037]).

The webcast player and accompanying slides may be accessed on the Investors section of Alkermes’ website at www.alkermes.com. The conference call may be accessed by dialing +1 888 424 8151 for U.S. callers and +1 847 585 4422 for international callers. The conference call ID number is 6037988.

A replay of the conference call will be available from 11:00 a.m. ET (4:00 p.m. BST) on Thursday, Oct. 26, 2017, through 5:00 p.m. ET (9:00 p.m. GMT) on Thursday, Nov. 2, 2017, and may be accessed by visiting Alkermes’ website or by dialing +1 888 843 7419 for U.S. callers and +1 630 652 3042 for international callers. The replay access code is 6037988.

On October 19, 2017 Five Prime Therapeutics, Inc. (NASDAQ:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, reported that it will report its third quarter 2017 financial results on Monday, November 6, 2017, after the U.S. financial markets close (Press release, Five Prime Therapeutics, OCT 19, 2017, View Source [SID1234521039]). Five Prime will host a conference call and live audio webcast on Monday, November 6, 2017, at 4:30 p.m. (ET)/1:30 p.m. (PT) to discuss the company’s financial results and provide a general business update.

The live audio webcast may be accessed through the “Events & Presentations” page in the “Investors” section of the company’s website at www.fiveprime.com. Alternatively, participants may dial (877) 878-2269 (domestic) or (253) 237-1188 (international) and refer to conference ID 95493696.

The archived conference call will be available on Five Prime’s website beginning approximately two hours after the event and will be archived and available for replay for at least 30 days after the event.

On October 19, 2017 Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) reported that it will host its third quarter 2017 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, November 2, 2017 (Press release, Ironwood Pharmaceuticals, OCT 19, 2017, View Source [SID1234521041]). Individuals interested in participating in the call should dial (877) 643-7155 (U.S. and Canada) or (914) 495-8552 (international) using conference ID number 1071726. To access the webcast, please visit the Investors section of Ironwood’s website at www.ironwoodpharma.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required.

The call will be available for replay via telephone starting November 2, 2017 at approximately 11:30 a.m. Eastern Time, running through 11:59 p.m. Eastern Time on November 9, 2017. To listen to the replay, dial (855) 859-2056 (U.S. and Canada) or (404) 537-3406 (international) using conference ID number 1071726. The archived webcast will be available on Ironwood’s website for 14 days beginning approximately one hour after the call has completed.